Robyn Konicki

University of North Carolina at Chapel Hill

Also affiliated with Center for Drug Evaluation and Research

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “FDA Approval Summary: Abatacept for the Prophylaxis of Acute GVHD”.

FDA Approval Summary: Abatacept for the Prophylaxis of Acute GVHD

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-25-0688

N/A

0.208DataRank · unranked

3 citations

Donna R. Rivera, Joseph Wynne, Jian Zhao, Robyn Konicki, Aida Kuzucan +8 more

Pharmacokinetic Considerations for Optimizing Inhaled Spray-Dried Pyrazinoic Acid Formulations

Molecular Pharmaceutics(2023)10.1021/acs.molpharmaceut.3c00199

N/A

0DataRank · unranked

3 citations

Patrick O. Hanafin, Brittany K. Miller, Laura Rank, Sebastian Murcia, Christian Xander +11 more

FDA Approval Summary: Teclistamab–A Bispecific CD3 T-Cell Engager for Patients with Relapsed or Refractory Multiple Myeloma

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-1872

N/A

0DataRank · unranked

13 citations

Bindu Kanapuru, Jay Zhao, Lauren Price, Nan Zheng, Robyn Konicki +5 more

FDA Approval Summary: Axatilimab for Adult and Pediatric Patients Weighing at Least 40 Kilograms with Chronic GVHD after Two Prior Lines of Systemic Therapy

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-25-0896

N/A

0DataRank · unranked

4 citations

Kamar Godder, Jingyan Wang, Justin S. Collazo, Robyn Konicki, Moran Choe +15 more